UNSPSC 51283110: Clofazimine

This classification denotes an antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D959AE5USF. European Medicines Agency schedules Clofazimine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06694MIG. Clofazimine generally arises in the molecular formula C27H22CL2N4. The term CLOFAZIMINE is an International Non-Proprietary Name or INN. CLOFAZIMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

SMILES: CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)CL)C=C1NC5=CC=C(C=C5)CL.

UNSPSC 51283110 Clofazimine, a Commodity code, shows limited recent state and local procurement activity directly aligned with the code's pharmaceutical scope. The code nominally covers clofazimine, a specialized antimicrobial agent used in treating leprosy and atypical mycobacterial infections; however, recent opportunities tagged under this code do not reflect procurement of clofazimine itself. Instead, state and local buyers are using related codes or broader pharmaceutical categories to solicit naloxone, medical and first aid supplies for emergency response, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products through cooperative purchasing vehicles. The issuing bodies include county health departments (Seminole County, Florida), municipal fire and emergency services (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local jurisdictions across multiple states including Oregon). When pharmaceutical and medical-supply procurement does appear, it targets high-volume, commonly used items with quarterly or annual delivery cycles rather than specialized antimicrobial therapeutics.

Recent representative opportunities illustrate the mismatch. Seminole County, Florida released IFB 60459723LAS in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, deadline July 26, 2023. The City of Tampa posted IFB 26P00145 in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a deadline of March 13, 2026; this procurement is designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. These solicitations reveal state and local procurement emphasis on emergency-response consumables, high-volume generics, and cooperative multi-jurisdiction purchasing rather than specialty pharmaceuticals such as clofazimine.